Global Drug-Device Combination Market, By Product (Auto-Injector, Microneedle Patch, Digital Pill, Smart Inhaler, Drug Delivery Hydrogels, Drug-Eluting Lens and Others, Application Type (Orthopedic Diseases, Respiratory Diseases, Diabetes, Oncology, Cardiovascular Diseases, and Others), End User (Clinics, Hospitals, Home Care Settings, Ambulatory Care Centers and Others), Distribution Channel (Direct Tender, Retail Sales and Others) – Industry Trends and Forecast to 2031.
Drug-Device Combination Market Analysis and Size
Government health organizations, particularly the U.S. FDA's Office of Combination Products, play a crucial role in ensuring patient safety by regulating drug-device combination products. This initiative addresses challenges and ensures consistent and effective regulation. In response to increasing demand, multinational pharmaceutical companies are anticipated to accelerate the development of clinical medications and devices, focusing on advanced medication delivery systems.
Data Bridge Market Research analyses that the global drug-device combination market which was USD 15,633.36 million in 2023, is expected to reach USD 34,002.04 million by 2031, and is expected to undergo a CAGR of 10.2% during the forecast period of 2024 to 2031. This indicates that the market value. “Auto-injector” dominates the product segment of the global drug-device combination market owing to the growing global demand for medical devices catering to patient treatment needs. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Drug-Device Combination Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2024 to 2031 |
|
Base Year |
2023 |
|
Historic Years |
2022 (Customizable to 2016-2021) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
Product (Auto-Injector, Microneedle Patch, Digital Pill, Smart Inhaler, Drug Delivery Hydrogels, Drug-Eluting Lens and Others), Application Type (Orthopedic Diseases, Respiratory Diseases, Diabetes, Oncology, Cardiovascular Diseases, and Others), End User (Clinics, Hospitals, Home Care Settings, Ambulatory Care Centers and Others), Distribution Channel (Direct Tender, Retail Sales and Others) |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America. |
|
Market Players Covered |
Medtronic (Ireland), Zimmer Biomet (U.S.), Amgen Inc. (U.S.), MediPrint (U.S.), Propeller Health (U.S.), BD (U.S.), CosMED Pharmaceutical Co., Ltd (Japan), Micron Biomedical, Inc.(U.S.), Findair Sp. z o. o. (Poland), MetP Pharma AG (Switzerland), SONCEBOZ (Switzerland), Eitan Medical (Israel), Vaxess Technologies Inc. (U.S.), UBCUJECT Aps (Denmark), E3D Elcam Drug[JS3] Delivery Devices (Israel) OcuMedic (U.S.), GlaxoSmithKline plc (U.K.), Bayer AG (Germany), NanoPass (Israel), Sensirion AG Switzerland (Switzerland), Janssen Pharmaceuticals, Inc. (a subsidiary of Johnson & Johnson Services, Inc.) (U.S.), Insulet Corporation (U.S.), TheraJect (U.S.), Otsuka America Pharmaceutical, Inc. (U.S.), Raphas Co., Ltd. (South Korea), EOFLOW CO., LTD. (South Korea), CGbio (South Korea) |
|
Market Opportunities |
|
Market Definition
A drug-device combination refers to a product that combines a pharmaceutical substance with a medical device, aiming to enhance treatment efficacy or delivery. These products, such as drug-eluting stents or inhalers, integrate drugs and devices to provide targeted therapy, improved patient outcomes, and enhanced delivery mechanisms in medical treatments.
Drug-Device Combination Market Dynamics
Drivers
- Increasing prevalence of chronic disease
The surge in chronic diseases drives the drug-device combination market by prompting the creation of integrated solutions. These combinations deliver superior therapeutic outcomes, addressing specific patient needs and contributing to an evolving treatment landscape for chronic conditions. This dynamic response to healthcare challenges underscores the growing significance of innovative, integrated approaches in disease management.
- Demand for minimally invasive therapies
The increasing demand for minimally invasive therapies propels the drug-device combination market by fostering the creation of products with targeted and efficient delivery mechanisms. This preference reflects a growing trend towards less invasive treatment options, driving innovation in drug-device combinations to enhance therapeutic effectiveness while minimizing patient discomfort and recovery times.
Opportunities
- Rising aging population
The rising global aging population creates a substantial market opportunity for drug-device combinations, as elderly individuals demand targeted and efficient healthcare solutions. These innovative combinations cater to the unique needs of aging patients, addressing age-related health challenges and positioning the market as a crucial player in geriatric care.
- Market Expansion in Emerging Economies
Market expansion in emerging economies presents a significant opportunity for the drug-device combination market. Growing healthcare infrastructure in these regions creates a favorable environment, fostering increased adoption and accessibility of innovative drug-device combinations. This expansion aligns with the rising demand for advanced healthcare solutions, driving market growth and penetration.
Restraints/Challenges
- Regulatory complexity
Regulatory complexity hampers the drug-device combination market by creating hindrence in navigating intricate and evolving frameworks. Compliance with both pharmaceutical and medical device regulations adds complexity, impacting the approval process and hindering the seamless development and commercialization of these innovative products.
- Risk of Uncertain Classification
The risk of uncertain classification poses a challenge in the drug-device combination market, complicating regulatory pathways and approval processes. Ambiguities in determining the appropriate classification for these products create uncertainties, potentially delaying market entry and hindering manufacturers' ability to navigate regulatory requirements effectively.
This global drug-device combination market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the surgical microscopes market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In August 2022, Medtronic introduced its newest drug-eluting coronary stent, the Onyx Frontier drug-eluting stent (DES). The DES combines the best-in-class stent platform with an improved delivery mechanism to improve deliverability and acute performance in the most difficult patients
- In August 2022, Terumo Corporation introduced 'G-Lasta Subcutaneous Injection 3.6 mg BodyPod,' a drug-device combination developed with Kyowa Kirin Co., Ltd. Approved by Japan's Ministry of Health, Labour, and Welfare, this innovative product showcases collaboration in delivering advanced healthcare solutions, further expanding the market for effective drug-device combinations
- In November 2021, Becton, Dickinson, and Company introduced the BD UltraSafe Plus 2.25 mL Passive Needle Guard in drug-device combination products. The BD UltraSafe Plus 2.25 mL system, when paired with a prefillable syringe, allows for the subcutaneous delivery of biologic solutions with viscosities up to 30 cP and fill volumes up to 2 mL
- In August 2021, SINOMED announced the first commercial implantation of the HT Supreme Drug-Eluting Stent (DES) at University Hospital Galway in conjunction with the National University of Ireland Galway (NUI Galway), kicking off the European rollout. This will most likely aid interventional cardiologists in treating patients with coronary artery disease (CAD) who have narrow arteries that are generally untreatable during percutaneous coronary intervention (PCI) with larger stent technology
Global Drug-Device Combination Market Scope
The global drug-device combination market is segmented on the basis of product, application, end user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Auto-Injector
- Microneedle Patch
- Digital Pill
- Smart Inhaler
- Drug Delivery Hydrogels
- Drug-Eluting Lens
- Others
Application Type
- Orthopedic Diseases
- Respiratory Diseases
- Diabetes
- Oncology
- Cardiovascular Diseases
- Others
End User
- Clinics
- Hospitals
- Home Care Settings
- Ambulatory Care Centers
- Others
Distribution Channel
- Direct Tender
- Retail Sales
- Others
Drug-Device Combination Market Regional Analysis/Insights
The global drug-device combination market is analysed and market size insights and trends are provided by country, product, application, end user, and distribution channel as referenced above.
The countries covered in the global drug-device combination market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is projected to secure a substantial market share in the global drug-device combination market. This is attributed to the region's robust healthcare infrastructure, heightened awareness of drug-device combinations, and their widespread adoption. The prevalence of chronic cases further fuels the market's growth, making North America a key player in this evolving healthcare landscape.
Asia-Pacific is the fastest-growing market in the global drug-device combination market from 2024 to 2031. Fueled by a large population, growing technology adoption, demand for personalized medicine, and a rising incidence of chronic diseases, the region experiences substantial expansion, making it a pivotal player in the evolving landscape of drug-device combination products.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The global drug-device combination market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global drug-device combination market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global drug-device combination market. The data is available for historic period 2016-2021.
Competitive Landscape and Drug-Device Combination Market Share Analysis
The global drug-device combination market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global drug-device combination market.
Some of the major players operating in the global drug-device combination market are:
- Medtronic (Ireland)
- Zimmer Biomet (U.S.)
- Amgen Inc. (U.S.)
- MediPrint (U.S.)
- Propeller Health (U.S.)
- BD (U.S.)
- CosMED Pharmaceutical Co., Ltd (Japan)
- Micron Biomedical, Inc.(U.S.)
- Findair Sp. z o. o. (Poland)
- MetP Pharma AG (Switzerland)
- SONCEBOZ (Switzerland)
- Eitan Medical (Israel)
- Vaxess Technologies Inc. (U.S.)
- UBCUJECT Aps (Denmark)
- E3D Elcam Drug Delivery Devices (Israel)
- OcuMedic(U.S.)
- GlaxoSmithKline plc (U.K.)
- Bayer AG (Germany)
- NanoPass (Israel)
- Sensirion AG Switzerland (Switzerland)
- Janssen Pharmaceuticals, Inc. (a subsidiary of Johnson & Johnson Services, Inc.) (U.S.)
- Insulet Corporation (U.S.)
- TheraJect (U.S.)
- Otsuka America Pharmaceutical, Inc. (U.S.)
- Raphas Co., Ltd. (South Korea)
- EOFLOW CO., LTD. (South Korea)
- CGbio (South Korea)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
- introduction
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- OVERVIEW of GLOBAL DRUG-DEVICE COMBINATION MARKET
- LIMITATIONS
- MARKETS COVERED
- MARKET SEGMENTATION
- MARKETS COVERED
- geographical scope
- years considered for the study
- currency and pricing
- DBMR TRIPOD DATA VALIDATION MODEL
- MULTIVARIATE MODELLING
- PRODUCT type LIFELINE CURVE
- primary interviews with key opinion leaders
- DBMR MARKET POSITION GRID
- market application coverage grid
- vendor share analysis
- secondary sourcEs
- assumptions
- EXECUTIVE SUMMARY
- premium insights
- PATENT ANALYSIS
- MANUFACTURING PROCESS OF COMBINATION PRODUCTS
- APPROVAL BY AGENCY
- PATENT GRANT
- PATENT CERTIFICATIONS:
- Pipeline analysis
- REGULATORY FRAMEWORKS:
- U.S.
- EUROPE
- CANADA
- AUSTRALIA
- JAPAN
- CHINA
- SOUTH KOREA
- regional Summary
- North America Drug-Device Combination Market
- OVERVIEW
- Europe Drug-Device Combination Market
- OVERVIEW
- Asia-Pacific Drug-Device Combination Market
- OVERVIEW
- Middle East and Africa Drug-Device Combination Market
- OVERVIEW
- South America Drug-Device Combination Market
- OVERVIEW
- Market Overview
- Drivers
- INCREASING PREVALENCE OF chronic diseases
- Growing geriatric population
- Escalation in innovation and technologies
- Rising rates of obesity
- RESTRAINTS
- product recalls
- Risk associated with the combiNAtion products
- opportunities
- RISING EXPENDITURE ON HEALTHCARE
- STRATEGIC INITIATIVES BY KEY MARKET PLAYERS
- Growing support by healthcare organizations and government bodies
- INCREASE IN R&D ACTIVITIES BY MEDICAL DEVICE COMPANIES
- Challenge
- STRICT REGULATORY FRAMEWORK
- Impact Of COVID-19 Pandemic On The Global Drug-Device Combination Market
- IMPACT ON PRICE
- IMPACT ON SUPPLY CHAIN
- IMPACT ON DEMAND
- STRATEGIC DECISIONS FOR MANUFACTURERS
- CONCLUSION
- GLOBAL DRUG-DEVICE COMBINATION MARKET, By product
- overview
- Auto-Injector
- WEARABLE AUTO-INJECTOR
- HAND HELD AUTO-INJECTOR
- Microneedle Patch
- digital pill
- Smart Inhaler
- Drug Delivery Hydrogels
- Drug-Eluting Lens
- others
- GLOBAL DRUG-DEVICE COMBINATION MARKET, By application
- overview
- Orthopedic Diseases
- Respiratory Diseases
- Diabetes
- Oncology
- Cardiovascular Diseases
- others
- global drug-device combination MARKET, BY end user
- overview
- clinics
- hospitals
- home care settings
- ambulatory care centers
- others
- global drug-device combination MARKET, BY distribution channel
- overview
- direct tender
- retails sales
- others
- GLOBAL drug-device combination MARKET, BY REGION
- overview
- North AMERICA
- U.S.
- Canada
- Mexico
- Europe
- germany
- france
- u.k.
- italy
- spain
- russia
- switzerland
- turkey
- belgium
- netherlands
- rest of europe
- Asia-Pacific
- japan
- china
- south korea
- india
- australia
- singapore
- thailand
- malaysia
- indonesia
- Philippines
- rest of Asia-Pacific
- South America
- brazil
- rest of south america
- Middle east and africa
- south africa
- rest of middle east and africa
- Global Drug-device combination Market: COMPANY landscape
- company share analysis: Global
- company share analysis: North America
- company share analysis: Europe
- company share analysis: Asia-Pacific
- Swot analysis
- Company profile
- Janssen Pharmaceuticals, Inc. (a subsidiary of Johnson & Johnson Services, Inc.)
- COMPANY SNAPSHOT
- Revenue analysis
- COMPANY SHARE ANALYSIS
- PRODUCT PORTFOLIO
- Recent development
- Amgen Inc.
- COMPANY SNAPSHOT
- Revenue analysis
- COMPANY SHARE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTs
- GlaxoSmithKline plc
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- COMPANY SHARE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- BD
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- COMPANY SHARE ANALYSIS
- PRODUCT PORTFOLIO
- recent developmentS
- MEDTRONIC
- COMPANY SNAPSHOT
- Revenue analysis
- COMPANY SHARE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Bayer AG
- COMPANY SNAPSHOT
- Revenue analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- CGBIO
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- CosMED Pharmaceutical Co.Ltd.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- E3D Elcam Drug Delivery Devices
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Eitan Medical
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- EOFLOW CO., LTD.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Findair Sp. z o. o.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Insulet Corporation
- COMPANY SNAPSHOT
- Revenue analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Mediprint
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- MetP Pharma AG
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Micron Biomedical, Inc.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- NanoPass
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- OcuMedic
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Otsuka America Pharmaceutical, Inc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- PROPELLER HEALTH
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- RAPHAS CO., LTD.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Sensirion AG Switzerland
- COMPANY SNAPSHOT
- revenue analysis
- PRODUCT PORTFOLIO
- Recent development
- . SONCEBOZ
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Subcuject Aps
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- TheraJect
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Vaxess Technologies Inc.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- VAXXAS
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- YPSOMED
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Zimmer Biomet
- COMPANY SNAPSHOT
- Revenue analysis
- PRODUCT PORTFOLIO
- Recent development
- questionnaire
- related reports
List of Table
TABLE 1 Global DRUG-DEVICE COMIBINATION Market, pipeline analysis
TABLE 2 Most obese countries of Asia-Pacific 2020
TABLE 3 GLOBAL DRUG-DEVICE COMBINATION MARKET, By Product, 2019-2028 (USD million)
TABLE 4 Global Auto-Injector in Drug-Device Combination Market, 2019-2028 (USD Million)
TABLE 5 Global Auto-Injector in Drug-Device Combination Market, By Product, 2019-2028 (USD Million)
TABLE 6 Global Microneedle Patch in Drug-Device Combination Market, 2019-2028 (USD Million)
TABLE 7 Global Digital Pill in Drug-Device Combination Market, 2019-2028 (USD Million)
TABLE 8 Global Smart Inhaler in Drug-Device Combination Market, 2019-2028 (USD Million)
TABLE 9 Global Drug Delivery Hydrogels in Drug-Device Combination Market, 2019-2028 (USD Million)
TABLE 10 Global Drug-Eluting Lens in Drug-Device Combination Market, 2019-2028 (USD Million)
TABLE 11 Global Others in Drug-Device Combination Market, 2019-2028 (USD Million)
TABLE 12 Global Drug-Device Combination Market, By Application, 2019-2028 (USD Million)
TABLE 13 Global Orthopedic Diseases in Drug-Device Combination Market, 2019-2028 (USD Million)
TABLE 14 Global Respiratory Diseases in Drug-Device Combination Market, 2019-2028 (USD Million)
TABLE 15 Global Diabetes in Drug-Device Combination Market, 2019-2028 (USD Million)
TABLE 16 Global Oncology in Drug-Device Combination Market, 2019-2028 (USD Million)
TABLE 17 Global Cardiovascular Diseases in Drug-Device Combination Market, 2019-2028 (USD Million)
TABLE 18 Global Others in Drug-Device Combination Market, 2019-2028 (USD Million)
TABLE 19 global drug-device combination Market, By end user, 2019-2028 (USD MILLION)
TABLE 20 global clinics in drug-device combination MARKET, By Region, 2019-2028 (USD MILLION)
TABLE 21 globaL hospitals in drug-device combination MARKET, By Region, 2019-2028 (USD MILLION)
TABLE 22 globaL home care settings in drug-device combination MARKET, By Region, 2019-2028 (USD MILLION)
TABLE 23 globaL ambulatory care centers in drug-device combination MARKET, By Region, 2019-2028 (USD MILLION)
TABLE 24 globaL ambulatory care centers in drug-device combination MARKET, By Region, 2019-2028 (USD MILLION)
TABLE 25 global drug-device combination MARKET, By distribution channel 2019-2028 (USD MILLION)
TABLE 26 global direct tender in drug-device combination MARKET, By Region, 2019-2028 (USD MILLION)
TABLE 27 global retail sales in drug-device combination MARKET, By Region, 2019-2028 (USD MILLION)
TABLE 28 global others in drug-device combination MARKET, By Region, 2019-2028 (USD MILLION)
TABLE 29 GLOBAL drug-device combination market, By region, 2019-2028 (usd MILLION )
TABLE 30 NORTH AMERICA DRUG-DEVICE COMBINATION market, By Country, 2019-2028 (USD Million)
TABLE 31 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 32 NORTH AMERICA AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 33 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)
TABLE 34 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)
TABLE 35 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 36 U.S. DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 37 U.S. AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 38 U.S. DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)
TABLE 39 U.S. DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)
TABLE 40 U.S. DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 41 CANADA DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 42 CANADA AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 43 CANADA DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)
TABLE 44 CANADA DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)
TABLE 45 CANADA DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 46 MEXICO DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 47 MEXICO AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 48 MEXICO DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)
TABLE 49 MEXICO DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)
TABLE 50 MEXICO DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 51 EUROPE DRUG-DEVICE COMBINATION market, By Country, 2019-2028 (USD Million)
TABLE 52 EUROPE DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 53 EUROPE AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 54 EUROPE DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)
TABLE 55 EUROPE DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)
TABLE 56 EUROPE DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 57 GERMANY DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 58 GERMANY AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 59 GERMANY DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)
TABLE 60 GERMANY DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)
TABLE 61 GERMANY DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 62 FRANCE DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 63 FRANCE AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 64 FRANCE DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)
TABLE 65 FRANCE DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)
TABLE 66 FRANCE DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 67 U.K. DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 68 U.K. AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 69 U.K. DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)
TABLE 70 U.K. DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)
TABLE 71 U.K. DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 72 ITALY DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 73 ITALY AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 74 ITALY DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)
TABLE 75 ITALY DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)
TABLE 76 ITALY DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 77 SPAIN DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 78 SPAIN AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 79 SPAIN DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)
TABLE 80 SPAIN DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)
TABLE 81 SPAIN DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 82 RUSSIA DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 83 RUSSIA AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 84 RUSSIA DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)
TABLE 85 RUSSIA DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)
TABLE 86 RUSSIA DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 87 SWITZERLAND DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 88 SWITZERLAND AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 89 SWITZERLAND DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)
TABLE 90 SWITZERLAND DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)
TABLE 91 SWITZERLAND DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 92 TURKEY DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 93 TURKEY AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 94 TURKEY DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)
TABLE 95 TURKEY DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)
TABLE 96 TURKEY DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 97 belgium DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 98 BELGIUM AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 99 BELGIUM DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)
TABLE 100 BELGIUM DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)
TABLE 101 BELGIUM DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 102 NETHERLANDS DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 103 NETHERLANDS AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 104 NETHERLANDS DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)
TABLE 105 NETHERLANDS DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)
TABLE 106 NETHERLANDS DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 107 REST OF EUROPE DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 108 ASIA-PACIFIC DRUG-DEVICE COMBINATION market, By Country, 2019-2028 (USD Million)
TABLE 109 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 110 ASIA-PACIFIC AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 111 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)
TABLE 112 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)
TABLE 113 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 114 JAPAN DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 115 JAPAN AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 116 JAPAN DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)
TABLE 117 JAPAN DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)
TABLE 118 JAPAN DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 119 CHINA DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 120 CHINA AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 121 CHINA DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)
TABLE 122 CHINA DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)
TABLE 123 CHINA DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 124 SOUTH KOREA DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 125 SOUTH KOREA AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 126 SOUTH KOREA DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)
TABLE 127 SOUTH KOREA DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)
TABLE 128 SOUTH KOREA DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 129 INDIA DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 130 INDIA AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 131 INDIA DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)
TABLE 132 INDIA DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)
TABLE 133 INDIA DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 134 AUSTRALIA DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 135 AUSTRALIA AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 136 AUSTRALIA DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)
TABLE 137 AUSTRALIA DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)
TABLE 138 AUSTRALIA DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 139 SINGAPORE DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 140 SINGAPORE AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 141 SINGAPORE DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)
TABLE 142 SINGAPORE DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)
TABLE 143 SINGAPORE DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 144 THAILAND DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 145 THAILAND AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 146 THAILAND DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)
TABLE 147 THAILAND DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)
TABLE 148 THAILAND DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 149 MALAYSIA DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 150 MALAYSIA AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 151 MALAYSIA DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)
TABLE 152 MALAYSIA DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)
TABLE 153 MALAYSIA DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 154 indonesia DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 155 INDONESIA AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 156 INDONESIA DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)
TABLE 157 INDONESIA DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)
TABLE 158 INDONESIA DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 159 PHILIPPINES DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 160 PHILIPPINES AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 161 PHILIPPINES DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)
TABLE 162 PHILIPPINES DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)
TABLE 163 PHILIPPINES DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 164 REST OF ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 165 SOUTH AMERICA DRUG-DEVICE COMBINATION market, By Country, 2019-2028 (USD Million)
TABLE 166 SOUTH AMERICA DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 167 SOUTH AMERICA AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 168 SOUTH AMERICA DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)
TABLE 169 SOUTH AMERICA DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)
TABLE 170 SOUTH AMERICA DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 171 BRAZIL DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 172 BRAZIL AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 173 BRAZIL DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)
TABLE 174 BRAZIL DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)
TABLE 175 BRAZIL DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 176 Rest of SOUTH AMERICA DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 177 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION market, By Country, 2019-2028 (USD Million)
TABLE 178 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 179 MIDDLE EAST AND AFRICA AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 180 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)
TABLE 181 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)
TABLE 182 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 183 SOUTH AFRICA DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 184 SOUTH AFRICA AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
TABLE 185 SOUTH AFRICA DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)
TABLE 186 SOUTH AFRICA DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)
TABLE 187 SOUTH AFRICA DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 188 REST OF MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)
List of Figure
FIGURE 1 GLOBAL DRUG-DEVICE COMBINATION MARKET: segmentation
FIGURE 2 GLOBAL DRUG-DEVICE COMBINATION MARKET: data triangulation
FIGURE 3 GLOBAL DRUG-DEVICE COMBINATION MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL DRUG-DEVICE COMBINATION MARKET: global vs REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL DRUG-DEVICE COMBINATION MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL DRUG-DEVICE COMBINATION MARKET: Multivariate Modelling
FIGURE 7 GLOBAL DRUG-DEVICE COMBINATION MARKET: PRODUCT type LIFELINE CURVE
FIGURE 8 GLOBAL DRUG-DEVICE COMBINATION MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 9 GLOBAL DRUG-DEVICE COMBINATION MARKET: DBMR MARKET POSITION GRID
FIGURE 10 GLOBAL DRUG-DEVICE COMBINATION MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 11 GLOBAL DRUG-DEVICE COMBINATION MARKET: vendor share analysis
FIGURE 12 GLOBAL DRUG-DEVICE COMBINATION MARKET: SEGMENTATION
FIGURE 13 THE increasing prevalence of chronic diseases and rising geriatric population are expected to drive THE GLOBAL DRUG-DEVICE COMBINATION MARKET IN THE FORECAST PERIOD of 2021 to 2028
FIGURE 14 THE Auto-Injector segment is expected to account for the largest share of the GLOBAL DRUG-DEVICE COMBINATION MARKET IN THE Year 2021 & 2028
FIGURE 15 North America is expected to DOMINATE the GLOBAL DRUG-DEVICE COMBINATION MARKET, and IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 16 NORTH AMERICA is the fastest-growing market for global drug-device combination manufacturers in the forecast period of 2021 to 2028
FIGURE 17 Porter's 5 forces
FIGURE 18 Pestel's Model
FIGURE 19 DRIVERS, RESTRAINTS, Opportunities, and Challenges: GLOBAL DRUG-DEVICE COMBINATION MARKET
FIGURE 20 PREVALENCE OF ASTHMA IN THE FOLLOWING COUNTRIES.
FIGURE 21 INCIDENCE OF CANCER, WHICH INCREASES WITH AGE
FIGURE 22 AGEING POPULATION In the world (in millions)
FIGURE 23 North AMERICA AGEING POPULATION (In million)
FIGURE 24 Europe AGEING POPULATION (In million)
FIGURE 25 Asia-pacific AGEING POPULATION (In million)
FIGURE 26 Medical Device Spending vs. National Health Expenditures, 2016
FIGURE 27 GLOBAL DRUG-DEVICE COMBINATION MARKET: By PRODUCT, 2020
FIGURE 28 GLOBAL DRUG-DEVICE COMBINATION MARKET: By PRODUCT, 2019-2028 (USD million)
FIGURE 29 GLOBAL DRUG-DEVICE COMBINATION MARKET: By PRODUCT, CAGR (2021-2028)
FIGURE 30 GLOBAL DRUG-DEVICE COMBINATION MARKET: By PRODUCT, LIFELINE CURVE
FIGURE 31 GLOBAL DRUG-DEVICE COMBINATION MARKET: By APPLICATION, 2020
FIGURE 32 GLOBAL DRUG-DEVICE COMBINATION MARKET: By APPLICATION, 2019-2028 (USD million)
FIGURE 33 GLOBAL DRUG-DEVICE COMBINATION MARKET: By APPLICATION, CAGR (2021-2028)
FIGURE 34 GLOBAL DRUG-DEVICE COMBINATION MARKET: By APPLICATION, LIFELINE CURVE
FIGURE 35 global drug-device combination MARKET: BY END USER, 2020
FIGURE 36 global drug-device combination MARKET: BY product, 2021-2028 (USD MILLION)
FIGURE 37 global drug-device combination MARKET: BY product, CAGR (2021-2028)
FIGURE 38 global drug-device combination MARKET: BY product, LIFELINE CURVE
FIGURE 39 global drug-device combination MARKET: BY distribution channel, 2020
FIGURE 40 global drug-device combination MARKET: BY distribution channel, 2021-2028 (USD MILLION)
FIGURE 41 global drug-device combination MARKET: BY distribution channel, CAGR (2021-2028)
FIGURE 42 global drug-device combination MARKET: BY distribution channel, LIFELINE CURVE
FIGURE 43 GLOBAL drug-device combination market: SNAPSHOT (2020)
FIGURE 44 GLOBAL drug-device combination market: by region (2020)
FIGURE 45 GLOBAL drug-device combination market: by region (2021 & 2028)
FIGURE 46 GLOBAL drug-device combination market: by region (2020 & 2028)
FIGURE 47 GLOBAL drug-device combination market: by product (2021-2028)
FIGURE 48 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: SNAPSHOT (2020)
FIGURE 49 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2020)
FIGURE 50 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2021 & 2028)
FIGURE 51 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2020 & 2028)
FIGURE 52 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY product (2021-2028)
FIGURE 53 EUROPE DRUG-DEVICE COMBINATION MARKET: SNAPSHOT (2020)
FIGURE 54 EUROPE DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2020)
FIGURE 55 EUROPE DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2021 & 2028)
FIGURE 56 EUROPE DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2020 & 2028)
FIGURE 57 EUROPE DRUG-DEVICE COMBINATION MARKET: BY product (2021-2028)
FIGURE 58 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: SNAPSHOT (2020)
FIGURE 59 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2020)
FIGURE 60 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2021 & 2028)
FIGURE 61 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2020 & 2028)
FIGURE 62 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY product (2021-2028)
FIGURE 63 SOUTH AMERICA DRUG-DEVICE COMBINATION MARKET: SNAPSHOT (2020)
FIGURE 64 SOUTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2020)
FIGURE 65 SOUTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2021 & 2028)
FIGURE 66 SOUTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2020 & 2028)
FIGURE 67 SOUTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY product (2021-2028)
FIGURE 68 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: SNAPSHOT (2020)
FIGURE 69 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2020)
FIGURE 70 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2021 & 2028)
FIGURE 71 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2020 & 2028)
FIGURE 72 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY product (2021-2028)
FIGURE 73 GLOBAL DRUG-DEVICE COMBINATION MARKET: COMPANY SHARE 2020 (%)
FIGURE 74 North America Drug-device combination Market: company share 2020 (%)
FIGURE 75 Europe Drug-device combination Market: company share 2020 (%)
FIGURE 76 Asia-Pacific Drug-device combination Market: company share 2020 (%)
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
